Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NCOA4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NCOA4 is a protein involved in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with ALS, Aging, Als. Connected to 236 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | NCOA4 |
| Full Name | Nuclear Receptor Coactivator 4 |
| Chromosome | 10q11.23 |
| Protein Type | Receptor |
| Function | NCOA4 performs two major functions in the cell: |
| Primary Expression | human tissues: - Brain: Moderate expression in cortex, hippocampus, basal ganglia - Highe |
| Molecular Weight | 70 kDa |
| Pathways | Akt, Autophagy, FERRITINOPHAGY, Ferroptosis, Iron Metabolism |
| UniProt ID | Q9UBR1 |
| NCBI Gene ID | 8031 |
| Ensembl ID | ENSG00000135333 |
| OMIM | 605161 |
| GeneCards | NCOA4 |
| Human Protein Atlas | NCOA4 |
| Associated Diseases | Carcinoma, Cardiovascular, Hepatocellular Carcinoma, Lactation Dysfunction, Parkinson, Tumor |
| Known Drugs/Compounds | rapamycin, Salidroside |
| Interactions | ACETYL-COA, ACSL4, ACTB, AGER, ALOX, ALZHEIMER |
| SciDEX Hypotheses | FUS-ALS-Specific Ferroptosis Vulnerability Through |
| KG Connections | 453 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
NCOA4["NCOA4
(Nuclear Receptor
Coactivator 4)"]
FERRITINOPHAGY["Ferritinophagy
(Iron Release
from Ferritin)"]
AUTOPHAGY["Autophagy
(Cellular Degradation)"]
FERROPTOSIS["Ferroptosis
(Iron-dependent
Cell Death)"]
IRON_RELEASE["Free Iron
Release"]
IRON_OVERLOAD["Iron Overload
and Oxidative Stress"]
GPX4["GPX4
(Glutathione
Peroxidase 4)"]
SLC7A11["SLC7A11
(Cystine/Glutamate
Antiporter)"]
ALS["Amyotrophic
Lateral Sclerosis
(ALS)"]
MS["Multiple
Sclerosis
(MS)"]
PARKINSON["Parkinson's
Disease"]
NEURODEGENERATION["Neuronal
Death and
Degeneration"]
THERAPEUTIC["Therapeutic
Target"]
NCOA4 -->|"regulates"| FERRITINOPHAGY
NCOA4 -->|"regulates"| AUTOPHAGY
NCOA4 -->|"regulates"| FERROPTOSIS
FERRITINOPHAGY -->|"leads to"| IRON_RELEASE
IRON_RELEASE -->|"causes"| IRON_OVERLOAD
IRON_OVERLOAD -->|"promotes"| FERROPTOSIS
NCOA4 -->|"inhibits"| GPX4
GPX4 -->|"protects against"| FERROPTOSIS
SLC7A11 -->|"supports"| GPX4
FERROPTOSIS -->|"contributes to"| NEURODEGENERATION
IRON_OVERLOAD -->|"damages"| NEURODEGENERATION
NEURODEGENERATION -->|"manifests as"| ALS
NEURODEGENERATION -->|"manifests as"| MS
NEURODEGENERATION -->|"manifests as"| PARKINSON
NCOA4 -->|"potential"| THERAPEUTIC
style NCOA4 fill:#006494
style GPX4 fill:#1b5e20
style SLC7A11 fill:#1b5e20
style THERAPEUTIC fill:#1b5e20
style FERROPTOSIS fill:#ef5350
style IRON_OVERLOAD fill:#ef5350
style NEURODEGENERATION fill:#ef5350
style ALS fill:#5d4400
style MS fill:#5d4400
style PARKINSON fill:#5d4400
style FERRITINOPHAGY fill:#4a1a6b
style AUTOPHAGY fill:#4a1a6b| Target | Relation | Type | Str |
|---|---|---|---|
| Ferritinophagy | mediates | process | 0.95 |
| Ferritinophagy | activates | process | 0.95 |
| Lactation Dysfunction | causes | phenotype | 0.92 |
| ferritinophagy | mediates | process | 0.90 |
| Ferritin | mediates | protein | 0.90 |
| Ferritin | degrades | protein | 0.90 |
| FERRITIN | degrades | entity | 0.90 |
| ferritinophagy | regulates | pathway | 0.90 |
| Ferroptosis | promotes | process | 0.90 |
| Autophagy | associated_with | pathway | 0.90 |
| Ferroptosis | activates | pathway | 0.90 |
| Lactation Dysfunction | contributes_to | phenotype | 0.88 |
| Bovine Mastitis | therapeutic_target | disease | 0.88 |
| ferroptosis | regulates | process | 0.88 |
| Iron Metabolism | involved_in | pathway | 0.85 |
| Als | activates | disease | 0.85 |
| FERROPTOSIS | mediates | entity | 0.85 |
| Iron Metabolism | regulates | pathway | 0.85 |
| Cancer | activates | disease | 0.85 |
| Carcinoma | associated_with | disease | 0.85 |
| Iron-Dependent Cell Death | modulates | process | 0.85 |
| Ferritin Degradation | activates | process | 0.85 |
| oxidative stress | upregulates | process | 0.80 |
| ferroptosis | participates_in | pathway | 0.80 |
| FERROPTOSIS | activates | gene | 0.80 |
| CANCER | activates | gene | 0.80 |
| Autophagy | regulates | pathway | 0.80 |
| Ferroptosis | regulates | pathway | 0.80 |
| Hepatocellular Carcinoma | associated_with | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Ischemia | therapeutic_target | disease | 0.75 |
| FERRITINOPHAGY | regulates | pathway | 0.72 |
| APOPTOSIS | activates | gene | 0.70 |
| PTGS2 | associated_with | gene | 0.70 |
| MTOR | regulates | gene | 0.70 |
| Mtor | regulates | pathway | 0.70 |
| GPX4 | regulates | gene | 0.70 |
| Ferroptosis | therapeutic_target | pathway | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| FERROPTOSIS | inhibits | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Ferroptosis | inhibits | pathway | 0.70 |
| P62 | associated_with | gene | 0.70 |
| FERROPTOSIS | regulates | gene | 0.70 |
| Ferroptosis | involved_in | process | 0.70 |
| ALS | activates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Klebsiella Pneumoniae | activates | disease | 0.90 |
| Rotenone | upregulates | compound | 0.90 |
| Klebsiella pneumoniae | upregulates | compound | 0.90 |
| STAT3 | upstream_of | protein | 0.85 |
| Salidroside | modulates | compound | 0.85 |
| FTH1 | inhibits | gene | 0.80 |
| FTH1 | associated_with | gene | 0.80 |
| ATG | associated_with | gene | 0.80 |
| GPX4 | associated_with | gene | 0.80 |
| AUTOPHAGY | associated_with | gene | 0.80 |
| ROS | associated_with | gene | 0.80 |
| COL1A1 | associated_with | gene | 0.70 |
| FTH1 | activates | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| SLC7A11 | associated_with | gene | 0.70 |
| ELAVL1 | associated_with | gene | 0.70 |
| BECN1 | associated_with | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| MAP1LC3B | associated_with | gene | 0.70 |
| ELAVL1 | interacts_with | gene | 0.60 |
| FTH1 | interacts_with | gene | 0.60 |
| GOT1 | interacts_with | gene | 0.60 |
| GPT | interacts_with | gene | 0.60 |
| BECN1 | interacts_with | gene | 0.60 |
| MAP1LC3B | interacts_with | gene | 0.60 |
| GPX4 | interacts_with | gene | 0.60 |
| DMT1 | expressed_in | gene | 0.60 |
| FTH1 | expressed_in | gene | 0.60 |
| DMT1 | activates | gene | 0.60 |
| MITOCHONDRIAL DNA | associated_with | gene | 0.60 |
| ALOX | associated_with | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| MAO | regulates | gene | 0.60 |
| FERROPTOSIS | regulates | gene | 0.60 |
| XCT | expressed_in | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| BECN1 | mediates | entity | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| ACTB | interacts_with | gene | 0.60 |
| CGAS | associated_with | gene | 0.60 |
| TMEM173 | associated_with | gene | 0.60 |
| ARNTL | associated_with | gene | 0.60 |
| FANCD2 | associated_with | gene | 0.60 |
| UBIQUITIN | interacts_with | gene | 0.60 |
| COX2 | activates | gene | 0.60 |
| HIF | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| FUS-ALS-Specific Ferroptosis Vulnerability Through NCOA4-Med | 0.480 | - | Ferroptosis in ALS and motor neuron dise |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| S-equol-induced ferroptosis mechanism in TNBC cells | exploratory | Triple negative breast cancer | 0.900 | 0.00 | TNBC cell lines | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning NCOA4 in their description or question text
No additional research found